Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of travoprost ophthalmic solution USP, 0.004% (ionic buffered solution). Glenmark’s travoprost ophthalmic solution USP, 0.004% is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback